International Stem Cell Corporation’s Liver Program Receives Award – Wall Street Journal
|
International Stem Cell Corporation’s Liver Program Receives Award
Wall Street Journal International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO’s core technology, parthenogenesis … |
